Article
Effects of oral anticoagulant therapy and haplotype 1 of the endothelial protein C receptor gene on activated protein C levels.
Thrombosis and haemostasis - 1 Mar 2012
Medina Pilar, Bonet Elena, Navarro Silvia, Martos Laura, Estellés Amparo, Ferrando Fernando, Vicente Vicente, Bertina Rogier M, España Francisco
Abstract excerpt
Oral anticoagulants (OACs) reduce activated protein C (APC) plasma levels less than those of protein C (PC) in lupus erythematosus and cardiac patients. Carriers of the H1 haplotype of the endothelial PC receptor gene (PROCR) have higher APC levels than non-carriers. We aimed to confirm these results in a large group of patients treated with OACs because of venous thromboembolism (VTE) and to assess whether the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
